Oncology/Hematology

Other Cancers

Latest AI and machine learning research in other cancers for healthcare professionals.

8,907 articles
Stay Ahead - Weekly Other Cancers research updates
Subscribe
Browse Categories
Showing 701-720 of 8,907 articles

Repurposing Non-oncologic Drugs via Targeted Nanocarriers for Cancer Therapy: Mechanisms, Synergistic Combinations, and Clinical Translation.

The urgent need for innovative cancer therapies has driven increasing interest in repurposing drugs originally developed for non-oncological diseases. Several FDA-approved and clinically investigated agents, including mesalamine, celecoxib, gliclazide, metformin, itraconazole, and doxycycline, have shown anticancer potential through diverse mechanisms. However, despite their therapeutic potential,...

Jun 26 2026 42362822

CT-based radiomics as a non-invasive virtual biopsy for high PD-L1 expression prediction in non-small cell lung cancer.

PURPOSE: Non-small cell lung cancer (NSCLC) remains a major clinical challenge, with Programmed death-ligand 1 (PD-L1) expression serving as a crucial biomarker to guide immunotherapy. However, its current assessment through invasive biopsies may not capture tumor heterogeneity. This study explores the feasibility of a CT-based radiomics approach, combined with machine learning (ML), as a potentia...

Jun 26 2026 42363255
Identification and prognostic analysis of genes related to CTNNB1 mutations in hepatocellular carcinoma.

BACKGROUND: Mutations in CTNNB1 are recognized oncogenic drivers of hepatocellular carcinoma (HCC); however, the downstream effector molecules and the...

Jun 26 2026 42363289
Tumor ablation: emerging uses, challenges, and strategic implementation. A green paper by the Network of Expertise in Cancer (JANE-2), High Tech Medical Resources, network on Physical Methods of Tumor Ablation.

The field of oncology has witnessed remarkable progress with the integration of high-tech innovations in tumor ablation. Tumor ablation therapies, suc...

Jun 26 2026 42359759
Integrated single-cell RNA sequencing and Bulk-RNA technologies reveal the immunological characteristics of lactylation related-genes in glioblastoma.

OBJECTIVE: Glioblastoma (GBM) is the most aggressive type of intracranial malignant tumor, known for its extremely poor prognosis. Lactylation, a newl...

Jun 26 2026 42361107
Corneal nerve regeneration: treatments and monitoring approaches.

BACKGROUND: Diagnostics and therapeutics for corneal nerve pathologies are rapidly evolving, with continual advancements in imaging, laser, machine le...

Jun 25 2026 42343826
OpenIO: An open framework for AI-native immunotherapy.

We propose Open Immune Oncology (OpenIO), a framework integrating generative AI and omics to advance precision oncology. By leveraging biological scal...

Jun 25 2026 42349428
[An auxiliary diagnosis system for cervical intraepithelial neoplasia based on colposcopic images].

Cervical intraepithelial neoplasia is the primary type of cervical precancerous lesion; however, manual clinical diagnosis is prone to bias and has li...

Jun 25 2026 42366432
Integrating machine learning with histopathological, immunohistochemical, and PET parameters in the study of invasive breast carcinoma, no special type.

BACKGROUND: This study investigates the relationship between histopathological (HP) features, immunohistochemical (IHC) markers, 18F- FDG PET/CT param...

Jun 25 2026 42351264
Review Article: Advances in the Diagnosis of Dysplasia in Barrett's Oesophagus.

BACKGROUND: Barrett's oesophagus (BE), the precursor to oesophageal adenocarcinoma, progresses through a stepwise dysplastic sequence. Accurate dyspla...

Jun 25 2026 42351305
Heterogeneity Analyzed by CT-Based Habitat Analysis for Clinical Management of Cancers: A Narrative Review.

Tumors are highly heterogeneous, and whole-lesion radiomics analysis is a popular method for extracting texture features that reflect this heterogenei...

Jun 25 2026 42348293
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy.

Chimeric antigen receptor (CAR) T cells have demonstrated curative potential in hematologic cancers and increasing efficacy in solid tumors and non-ma...

Jun 25 2026 42349383
Development of a LASSO-based machine learning model for relapse prediction in lupus nephritis.

OBJECTIVE: To identify the predictors of renal relapse in patients with lupus nephritis (LN) and develop a predictive model. METHODS: The patients wit...

Jun 25 2026 42349918
Value operating system: a practical framework to measure outcomes-per-cost at the episode level.

OBJECTIVE: To specify a value operating system (VOS) and its executable metric-the Value Index (VI)-that expresses risk-adjusted outcomes-per-episode-...

Jun 25 2026 42349995
Prediction of cardiac arrest in patients with heart failure in Sweden: a registry study with development of a machine learning model.

OBJECTIVE: 30-day survival after cardiac arrest is low, 12.4% and 36% for out-of-hospital and in-hospital cardiac arrest, respectively. Heart failure ...

Jun 25 2026 42350023
IL4Rα blockade inhibits proliferation of malignant lymphocytes and the immunosuppressive tumor microenvironment of mycosis fungoides.

BACKGROUND: Limited therapeutic options are available for patients with advanced-stage mycosis fungoides (MF), and the 5-year survival rate is 25%. Du...

Jun 25 2026 42350047
Diagnosis of Small Focal Liver Lesions (≤2 cm): A Deep Learning Approach Based on B-Mode Ultrasound and Contrast-Enhanced Ultrasound.

BACKGROUND: To develop and validate a deep learning (DL) model based on feature fusion with B-mode ultrasound (BMUS) and contrast enhanced ultrasound ...

Jun 25 2026 42350195
Oral cancer in the era of precision medicine: molecular targets and technological innovations.

This topical Collection presents a series of studies that examine molecular mechanisms, diagnostic approaches, and therapeutic strategies relevant to ...

Jun 25 2026 42350464
A prediction model based on tumor immune microenvironment for immunotherapy response in gastric cancer.

This study aimed to develop a robust prediction model- using machine-learning algorithms based on the core indicators of the tumor immune microenviron...

Jun 25 2026 42350633
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

Immune-checkpoint inhibitors benefit a subset of patients with advanced cancer, and the metabolic determinants of response remain unclear. Here, using...

Jun 25 2026 42350644
Browse Categories